相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Vitamin D deficiency in children with epilepsy taking valproate and levetiracetam as monotherapy
Teodoro Dura-Trave et al.
EPILEPSY RESEARCH (2018)
Determinants of low bone mineral density in children with epilepsy
Choong Yi Fong et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
Levetiracetam and lamotrigine effects as mono- and polytherapy on bone mineral density in epileptic patients
Sahar Mohamed El-Haggar et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2018)
Bone mineral density evaluation o epileptic children on anti-epileptic medications
Nasr Mohamed M. Osman et al.
EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE (2017)
Bone mineral status in children with epilepsy: Biochemical and radiologic markers
Bothina Hasaneen et al.
JOURNAL OF PEDIATRIC NEUROSCIENCES (2017)
Third generation antiepileptic drug monotherapies in adults with epilepsy
Marco Mula
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Third generation antiepileptic drug monotherapies in adults with epilepsy
Marco Mula
EXPERT REVIEW OF NEUROTHERAPEUTICS (2016)
Effects of antiepileptic drugs on bone mineral density and bone metabolism in children: a meta-analysis
Ying Zhang et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2015)
Longitudinal Change of Vitamin D Status in Children With Epilepsy on Antiepileptic Drugs: Prevalence and Risk Factors
Yun-Jin Lee et al.
PEDIATRIC NEUROLOGY (2015)
Effects of Antiepileptic Drugs on Bone Health and Growth Potential in Children with Epilepsy
Peter Vestergaard
PEDIATRIC DRUGS (2015)
Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis
J. Ambroszkiewicz et al.
ADVANCES IN MEDICAL SCIENCES (2013)
The effect of levetiracetam on rat bone mass, structure and metabolism
Sona Fekete et al.
EPILEPSY RESEARCH (2013)
Bone disease during chronic antiepileptic drug therapy: General versus specific risk factors
Kim Beerhorst et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
Ideal characteristics of an antiepileptic drug: how do these impact treatment decisions for individual patients?
E. Trinka
ACTA NEUROLOGICA SCANDINAVICA (2012)
Bone mineral density in adult patients treated with various antiepileptic drugs
Simona Alexandra Beniczky et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2012)
Bone Mineral Accrual from 8 to 30 Years of Age: An Estimation of Peak Bone Mass
Adam D. G. Baxter-Jones et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
Vitamin D metabolism within bone cells: Effects on bone structure and strength
Paul H. Anderson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2011)
Fractures in epilepsy children
Anna Gniatkowska-Nowakowska
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2010)
Bone metabolism markers and ghrelin in boys at different stages of sexual maturity
Jaak Juerimaee et al.
ACTA PAEDIATRICA (2009)
Bone mineral density in children, adolescents, and young adults with epilepsy
Giangennaro Coppola et al.
EPILEPSIA (2009)
Predictors of bone density in ambulatory patients on antiepileptic drugs
Ghada El-Hajj Fuleihan et al.
BONE (2008)
Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy
Sina Nettekoven et al.
EUROPEAN JOURNAL OF PEDIATRICS (2008)
Levetiracetam, phenytoin, and valproate act differently on rat bone mass, structure and metabolism
Lise Sofie H. Nissen-Meyer et al.
EPILEPSIA (2007)
Two randomized vitamin D trials in ambulatory patients on anticonvulsants - Impact on bone
M. A. Mikati et al.
NEUROLOGY (2006)
Bone metabolism markers and bone mass in healthy pubertal boys and girls
SCCM van Coeverden et al.
CLINICAL ENDOCRINOLOGY (2002)
Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy
CY Guo et al.
EPILEPSIA (2001)
Epilepsy after the first drug fails: substitution or add-on?
P Kwan et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2000)
Management of epilepsy in adolescents and adults
MJ Brodie et al.
LANCET (2000)
Early identification of refractory epilepsy.
P Kwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)